Clinical trial
Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment
NCT02068625 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- September 30, 2010
- Completion date
- December 31, 2018
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.